Literature DB >> 14986169

Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese.

Koichi Furugaki1,2, Senji Shirasawa1, Naofumi Ishikawa3, Kunihiko Ito3, Koichi Ito3, Sumihisa Kubota4, Kanji Kuma4, Hajime Tamai4, Takashi Akamizu5, Hitomi Hiratani5, Masao Tanaka2, Takehiko Sasazuki6.   

Abstract

Autoimmune thyroid disease (AITD) is caused by an immune response to self-thyroid antigen. The cytotoxic T-lymphocyte antigen-4 ( CTLA4) gene, encoding a negative regulator of the T-lymphocyte immune response, had been reported to be associated and/or linked to AITD. Recently, AITD susceptibility in the Caucasians was mapped to the 6.1-kb 3'UTR of the CTLA4 gene, in which the three single-nucleotide polymorphisms (SNPs) CT60, JO31, and JO30 were strongly associated with AITD. In order to determine the association of the CTLA4 gene with AITD in the Japanese, case-control association analysis for the four SNPs of the CTLA4 gene using 380 AITD patients and 266 healthy controls was done. Among the SNPs examined, the SNP JO31 was most significantly associated with AITD in the Japanese, whereas the association of the JO30 with AITD was not observed. The frequency of the disease-susceptible G allele of the JO31 of the Japanese control was higher than that of the Caucasians (67.1% vs 50.2%); however, the G allele of the JO31 was associated with Graves' disease (GD) (67.1% vs 76.3%, P=0.0013) and AITD in the Japanese (67.1% vs 74.2%, P=0.0055). Furthermore, the G allele of the JO31 was associated with the increased risk for GD [ P=0.0051, odds ratio (OR)=1.7] and AITD ( P=0.016, OR=1.5) in a dominant model. These results suggested that the CTLA4 gene is involved in the susceptibility for GD and AITD in the Japanese.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986169     DOI: 10.1007/s10038-003-0120-5

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  14 in total

1.  The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.

Authors:  B Vaidya; H Imrie; P Perros; E T Young; W F Kelly; D Carr; D M Large; A D Toft; M I McCarthy; P Kendall-Taylor; S H Pearce
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

2.  The development of Graves' disease and the CTLA-4 gene on chromosome 2q33.

Authors:  J M Heward; A Allahabadia; M Armitage; A Hattersley; P M Dodson; K Macleod; J Carr-Smith; J Daykin; A Daly; M C Sheppard; R L Holder; A H Barnett; J A Franklyn; S C Gough
Journal:  J Clin Endocrinol Metab       Date:  1999-07       Impact factor: 5.958

3.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.

Authors:  Hironori Ueda; Joanna M M Howson; Laura Esposito; Joanne Heward; Hywel Snook; Giselle Chamberlain; Daniel B Rainbow; Kara M D Hunter; Annabel N Smith; Gianfranco Di Genova; Mathias H Herr; Ingrid Dahlman; Felicity Payne; Deborah Smyth; Christopher Lowe; Rebecca C J Twells; Sarah Howlett; Barry Healy; Sarah Nutland; Helen E Rance; Vin Everett; Luc J Smink; Alex C Lam; Heather J Cordell; Neil M Walker; Cristina Bordin; John Hulme; Costantino Motzo; Francesco Cucca; J Fred Hess; Michael L Metzker; Jane Rogers; Simon Gregory; Amit Allahabadia; Ratnasingam Nithiyananthan; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Polly Bingley; Kathleen M Gillespie; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîrgovişte; David A Savage; A Peter Maxwell; Dennis J Carson; Chris C Patterson; Jayne A Franklyn; David G Clayton; Laurence B Peterson; Linda S Wicker; John A Todd; Stephen C L Gough
Journal:  Nature       Date:  2003-04-30       Impact factor: 49.962

4.  Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23-q24 by multipoint affected sib-pair linkage analysis in Japanese.

Authors:  K Sakai; S Shirasawa; N Ishikawa; K Ito; H Tamai; K Kuma; T Akamizu; M Tanimura; K Furugaki; K Yamamoto; T Sasazuki
Journal:  Hum Mol Genet       Date:  2001-06-15       Impact factor: 6.150

5.  Linkage strategies for genetically complex traits. II. The power of affected relative pairs.

Authors:  N Risch
Journal:  Am J Hum Genet       Date:  1990-02       Impact factor: 11.025

6.  A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism.

Authors:  K Kotsa; P F Watson; A P Weetman
Journal:  Clin Endocrinol (Oxf)       Date:  1997-05       Impact factor: 3.478

Review 7.  Autoimmune thyroid disease: new models of cell death in autoimmunity.

Authors:  Giorgio Stassi; Ruggero De Maria
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

8.  Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease.

Authors:  H Uno; T Sasazuki; H Tamai; H Matsumoto
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

9.  CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.

Authors:  H Donner; H Rau; P G Walfish; J Braun; T Siegmund; R Finke; J Herwig; K H Usadel; K Badenhoop
Journal:  J Clin Endocrinol Metab       Date:  1997-01       Impact factor: 5.958

10.  HLA-A and DPB1 loci confer susceptibility to Graves' disease.

Authors:  R P Dong; A Kimura; R Okubo; H Shinagawa; H Tamai; Y Nishimura; T Sasazuki
Journal:  Hum Immunol       Date:  1992-11       Impact factor: 2.850

View more
  22 in total

Review 1.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-04-28       Impact factor: 4.132

Review 2.  GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis.

Authors:  Matthew J Simmonds
Journal:  Nat Rev Endocrinol       Date:  2013-03-26       Impact factor: 43.330

3.  Tremelimumab-Induced Graves Hyperthyroidism.

Authors:  Earn H Gan; Anna L Mitchell; Ruth Plummer; Simon Pearce; Petros Perros
Journal:  Eur Thyroid J       Date:  2017-03-14

4.  Genetics of autoimmune thyroid disease in the Lebanese population.

Authors:  C Farra; J Awwad; A Fadlallah; G Sebaly; G Hage; M Souaid; H Ashkar; R Medlej; M H Gannageh; G Halaby
Journal:  J Community Genet       Date:  2012-03-06

5.  Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis.

Authors:  Fuencisla Matesanz; Blanca Rueda; Gisela Orozco; Oscar Fernandez; Laura Leyva; Antonio Alcina; Javier Martín
Journal:  J Neurol       Date:  2005-03-17       Impact factor: 4.849

Review 6.  Genes and Sjögren's syndrome.

Authors:  Beth L Cobb; Christopher J Lessard; John B Harley; Kathy L Moser
Journal:  Rheum Dis Clin North Am       Date:  2008-11       Impact factor: 2.670

7.  Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial.

Authors:  Helen Gogas; Urania Dafni; Henry Koon; Maria Spyropoulou-Vlachou; Yannis Metaxas; Elizabeth Buchbinder; Eirini Pectasides; Dimosthenis Tsoutsos; Aristidis Polyzos; Alexandros Stratigos; Christos Markopoulos; Petros Panagiotou; George Fountzilas; Ourania Castana; Pantelis Skarlos; Michael B Atkins; John M Kirkwood
Journal:  J Transl Med       Date:  2010-11-03       Impact factor: 5.531

8.  Cytotoxic T lymphocyte-Associated Antigen +49G Variant Confers Risk for Anti-CCP- and Rheumatoid Factor-Positive Type of Rheumatoid Arthritis Only in Combination with CT60G Allele.

Authors:  Bernadett Farago; Peter Kisfali; Lili Magyari; Noemi Polgar; Bela Melegh
Journal:  Autoimmune Dis       Date:  2009-08-27

9.  Association of the CTLA4 gene CT60/rs3087243 single-nucleotide polymorphisms with Graves' disease.

Authors:  Weizhen Fang; Zhixian Zhang; Jin Zhang; Zhenhua Cai; Hua Zeng; Mei Chen; Junqi Huang
Journal:  Biomed Rep       Date:  2015-07-27

10.  Autoimmune thyroid disorders-An update.

Authors:  Manorama Swain; Truptirekha Swain; Binoy Kumar Mohanty
Journal:  Indian J Clin Biochem       Date:  2005-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.